Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway
Authors
Keywords
-
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-20
DOI
10.1007/s12272-020-01237-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Abstract 051: Oral Antihyperglycemic Therapy With a SGLT2 Inhibitor Reverses Cognitive Impairments in Elderly Diabetics
- (2019) Shaoxun Wang et al. HYPERTENSION
- Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
- (2019) Ryoichi Bessho et al. Scientific Reports
- Highly selective SGLT2 inhibitor dapagliflozin reduces seizure activity in pentylenetetrazol-induced murine model of epilepsy
- (2018) Mumin Alper Erdogan et al. BMC Neurology
- VEGF - A Stimulus for Neuronal Development and Regeneration in the CNS and PNS
- (2018) Verena Theis et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- VEGF attenuates 2-VO induced cognitive impairment and neuronal injury associated with the activation of PI3K/Akt and Notch1 pathway
- (2018) Ling Wang et al. EXPERIMENTAL GERONTOLOGY
- Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas
- (2018) Vladimir Kepe et al. JOURNAL OF NEURO-ONCOLOGY
- Sodium–Glucose Cotransporter–2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
- (2018) Caroline K. Kramer et al. Annual Review of Medicine
- A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor–dependent pathway after renal injury in mice
- (2018) Yifan Zhang et al. KIDNEY INTERNATIONAL
- Preconditioning exercise reduces brain damage and neuronal apoptosis through enhanced endogenous 14-3-3γ after focal brain ischemia in rats
- (2018) Shotaro Otsuka et al. Brain Structure & Function
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Hypoxia inducible factor-1 alpha stabilization for regenerative therapy in traumatic brain injury
- (2017) Mushfiquddin Khan et al. Neural Regeneration Research
- SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
- (2017) Piangkwan Sa-nguanmoo et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects
- (2017) Ioanna Andreadou et al. Frontiers in Physiology
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Global cerebral ischemia due to circulatory arrest: insights into cellular pathophysiology and diagnostic modalities
- (2016) Santosh K. Sanganalmath et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury
- (2016) Yoon-Kyung Chang et al. PLoS One
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- Protective Effect of Quercetin against Oxidative Stress and Brain Edema in an Experimental Rat Model of Subarachnoid Hemorrhage
- (2014) Yu-shu Dong et al. International Journal of Medical Sciences
- Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
- (2014) S. Ramakrishnan et al. Journal of Neuroimmune Pharmacology
- Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
- (2014) Anthony H Barnett et al. Lancet Diabetes & Endocrinology
- Protective effect of HIF-1α against hippocampal apoptosis and cognitive dysfunction in an experimental rat model of subarachnoid hemorrhage
- (2013) Yushu Dong et al. BRAIN RESEARCH
- Hypoxia-inducible Factor-1α (HIF-1α) Protein Diminishes Sodium Glucose Transport 1 (SGLT1) and SGLT2 Protein Expression in Renal Epithelial Tubular Cells (LLC-PK1) under Hypoxia
- (2013) Juan R. Zapata-Morales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
- (2013) Tim Heise et al. Diabetes Therapy
- Regional distribution of SGLT activity in rat brain in vivo
- (2012) Amy S. Yu et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pyruvate Protects the Brain Against Ischemia–Reperfusion Injury by Activating the Erythropoietin Signaling Pathway
- (2012) Myoung-Gwi Ryou et al. STROKE
- Long-term treatment with empagliflozin, a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats
- (2011) L. Thomas et al. DIABETES OBESITY & METABOLISM
- Estimation of Immunohistochemical Expression of VEGF in Ductal Carcinomas of the Breast
- (2011) Else Maae et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Nebivolol regulates eNOS and iNOS expressions and alleviates oxidative stress in cerebral ischemia/reperfusion injury in rats
- (2011) Gehan H. Heeba et al. LIFE SCIENCES
- Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α
- (2011) Molly E. Ogle et al. NEUROBIOLOGY OF DISEASE
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- The effects of propofol on hippocampal caspase-3 and Bcl-2 expression following forebrain ischemia–reperfusion in rats
- (2010) Jun Li et al. BRAIN RESEARCH
- Murine Neural Stem/Progenitor Cells Protect Neurons against Ischemia by HIF-1α–Regulated VEGF Signaling
- (2010) Kate M. Harms et al. PLoS One
- Mechanisms and targets for angiogenic therapy after stroke
- (2010) Deepti Navaratna et al. Cell Adhesion & Migration
- Glibenclamide Reduces Inflammation, Vasogenic Edema, and Caspase-3 Activation after Subarachnoid Hemorrhage
- (2008) J Marc Simard et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started